You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-small-cell lung cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation Trial in Fairfax (STX-721)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Fairfax, Virginia
    NEXT Virginia
Sep 18, 2023

Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 25, 2023

Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Oslo, Norway
    Pfizer Norway
Apr 17, 2023

NSCLC(NSCLC) Trial in Jinan (WX-0593 Tablets)

Not yet recruiting
  • Non-Small Cell Lung Cancer(NSCLC)
  • WX-0593 Tablets
  • Jinan, Shandong, China
    Shandong Cancer Hospital and Institute
Mar 1, 2023

NSCLC Trial in Shanghai (SI-B001, SI-B003)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 10, 2023

Non Small Cell Lung Cancer Trial (TGRX-326, Crizotinib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • (no location specified)
Oct 8, 2023

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

Not yet recruiting
  • Lung Cancer, Non-small Cell
  • Small Cell Lung Cancer
    • (no location specified)
    Nov 16, 2022

    Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

    Not yet recruiting
    • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    • (no location specified)
    May 8, 2023

    Stage IB Non-small Cell Lung Cancer

    Completed
    • Stage IB Non-Small Cell Lung Carcinoma
      • Shanghai, China
        180 Fenglin Road
      Jul 29, 2023

      NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)

      Not yet recruiting
      • Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
      • tereotactic body radiotherapy
      • (no location specified)
      Dec 1, 2023

      NSCLC Trial (V940, Pembrolizumab, Placebo)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • V940
      • +2 more
      • (no location specified)
      Oct 5, 2023

      Lung Cancer Trial (exercise)

      Not yet recruiting
      • Lung Cancer
      • exercise
      • (no location specified)
      Jul 17, 2023

      Learn About Dacomitnib in Non-small Cell Lung Cancer Which Has

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      Oct 4, 2023

      EGFR Mutant Advanced NSCLC Trial (BBT-207)

      Not yet recruiting
      • EGFR Mutant Advanced Non-Small Cell Lung Cancer
      • (no location specified)
      Jun 16, 2023

      NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +

      Recruiting
      • Non-Small Cell Lung Cancer
      • +2 more
      • Befotertinib + Icotinib placebo
      • Icotinib + Befotertinib placebo
      • Beijing, China
      • +2 more
      Sep 20, 2023

      Advanced Non Small Cell Lung Cancer Trial run by the National Cancer Institute (NCI) (aerosolized aztreonam, aerosolized

      Not yet recruiting
      • Advanced Non Small Cell Lung Cancer
      • aerosolized aztreonam
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Mar 28, 2023

      NSCLC Trial (SGN-B6A, docetaxel)

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      Aug 21, 2023

      NSCLC Trial in Shanghai (BL-M02D1)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Jul 10, 2023

      NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

      Not yet recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • MK-2870
      • +2 more
      • (no location specified)
      Oct 3, 2023

      NSCLC Trial (JDQ443)

      Not yet recruiting
      • NSCLC
      • (no location specified)
      Feb 2, 2023

      Non Small Cell Lung Cancer Recurrent Trial (Toripalimab, Anlotinib and Chemotherapy)

      Not yet recruiting
      • Non Small Cell Lung Cancer Recurrent
      • Toripalimab, Anlotinib and Chemotherapy
      • (no location specified)
      Apr 24, 2023

      NSCLC Trial in Beijing (Pyrotinib)

      Recruiting
      • Non-small Cell Lung Cancer
      • Beijing, Beijing, China
        Peking Union Medical College
      Feb 20, 2023

      NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • Crizotinib - Usual
      • Crizotinib - Study
      • Rockville, Maryland
        Medicine Invention Design, Inc. - IORG0007849
      Oct 5, 2023

      Non-small Cell Lung Cancer With Central Nervous System

      Recruiting
      • Lung Cancer With Central Nervous System Metastasis
      • lung cancer with brain /leptomeningeal metastasis
      • Taipei, Taiwan
        National Taiwan University Hospital
      Sep 4, 2023

      Lung Cancer Trial (Sacituzumab Govitecan, Pembrolizumab)

      Not yet recruiting
      • Lung Cancer
      • (no location specified)
      Sep 20, 2023